Anesthesia for electroconvulsive therapy: clinical experience

Simple item page
dc.catalogadoraba
dc.contributor.authorGonzález, Aridane G.
dc.contributor.authorCortínez, Luis I.
dc.contributor.authorCuadra F., Juan Carlos de la
dc.contributor.authorCarrasco, Elena
dc.contributor.authorRioseco, Alonso
dc.contributor.authorLéniz, Pamela Wisnia
dc.date.accessioned2024-03-22T18:38:53Z
dc.date.available2024-03-22T18:38:53Z
dc.date.issued2007
dc.description.abstractOBJECTIVE: To assess the utility of propofol and succinylcholine in obtaining optimal convulsions and assuring patient safety during electroconvulsive therapy. PATIENTS AND METHODS: This was a prospective observational study of patients undergoing electroconvulsive therapy under general anesthesia with propofol and succinylcholine. We recorded patient characteristics, doses of propofol and succinylcholine, electroencephalographically-recorded duration of convulsions, and complications. Descriptive statistics were compiled and the data were subjected to analysis of correlations, comparison with the Student t test for independent samples, the Mann-Whitney U test, and analysis of variance. RESULTS: We studied 108 patients, 62% women and 38% men, 80% classified as ASA 1 and 20% as ASA 2. The patients underwent 844 sessions of electroconvulsive therapy; their mean (SD) age was 39.95 (18.09) years. The doses of propofol and succinylcholine were 1.34 (0.32) mgxkg(-1) and 1.35 (0.26) mgxkg(-1), respectively. The mean recorded duration of the first convulsion (29.87 [22.42] seconds) was negatively correlated with age (r = -0.12) and unrelated to propofol dose (r = 0.06) or body weight (r = 0.02). Male and schizophrenic patients had longer-lasting convulsions (P < .01). Cardiovascular complications occurred in 2.4% and psychomotor agitation in 1.4%; there were no respiratory complications, musculoskeletal injuries, nausea, or vomiting. CONCLUSIONS: Electroconvulsive therapy can be safely applied in an operating room or similar space undergeneral anesthesia and with a neuromuscular blockade in order to prevent psychological or musculoskeletal trauma. Propofol did not affect the convulsions at the dosages administered.
dc.fechaingreso.objetodigital2024-03-22
dc.fuente.origenScopus
dc.identifier.issn0034-9356
dc.identifier.pubmedid17953335
dc.identifier.scopusidSCOPUS_ID:38449090280
dc.identifier.urihttps://repositorio.uc.cl/handle/11534/84687
dc.information.autorucEscuela de Medicina; Cuadra F., Juan Carlos de la; 0000-0002-3868-0764; 58562
dc.information.autorucEscuela de Medicina; Rioseco, Alonso; S/I; 61709
dc.issue.numero7
dc.language.isoes
dc.nota.accesocontenido parcial
dc.pagina.final420
dc.pagina.inicio414
dc.revistaRevista española de anestesiología y reanimación
dc.rightsacceso restringido
dc.subject.ddc610
dc.subject.deweyMedicina y saludes_ES
dc.titleAnesthesia for electroconvulsive therapy: clinical experience
dc.title.alternativeAnestesia en terapia electroconvulsiva. Experiencia clínica
dc.typeartículo
dc.volumen54
sipa.codpersvinculados58562
sipa.codpersvinculados61709
sipa.trazabilidadScopus;12-10-2021
Files
Original bundle
Now showing 1 - 2 of 2
Thumbnail Image
Name:
Anestesia en terapia electroconvulsiva.pdf
Size:
73.23 KB
Format:
Adobe Portable Document Format
Description:
Download
Thumbnail Image
Name:
Anesthesia for electroconvulsive therapy clinical experience.pdf
Size:
101.65 KB
Format:
Adobe Portable Document Format
Description:
Download
Collections
Artículos de revistas